
Equateq and Dignity Sciences Announce IP and Supply Deal
Equateq and Dignity Sciences Ltd today announced a two-tier strategic deal comprising a supply agreement, and the assignment of IP covering the use of synthetic lipids for the topical treatment of hyper-proliferative skin conditions.



Higher concentrates at greater efficiency are achievable by converting TG oils to Free Fatty Acid or Ethyl Ester form followed by crystallization or distillation. We typically produce this specification as an interim feedstock for making our Maxomega range. Both EE and FFA forms may then be re-constituted under mild conditions to a Triglyceride form.
Our Intermediates Range: highly concentrated fatty acids.